SL
KRSA

Siren LLC’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Siren LLC’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,515
Closed -$147K – 110
2025
Q4 		$147K Sell
16,515
-79
-0.5% -$141 ﹤0.01% 113
2025
Q3 		$267K Hold
16,594
– – 0.01% 113
2025
Q2 		$338K Hold
16,594
– – 0.02% 105
2025
Q1 		$290K Hold
16,594
– – 0.02% 114
2024
Q4 		$374K Hold
16,594
– – 0.02% 115
2024
Q3 		$301K Buy
+16,594
New +$48.8K 0.02% 109

Other funds holding KRSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Siren LLC's KRSA Position: Q1 2026 in Review

Siren LLC sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 16,515 shares — an estimated $147K sold.

Siren LLC first reported a position in KRSA in Q3 2024 and held it in 6 quarters. The position peaked at $374K in Q4 2024. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • Siren LLC reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Siren LLC sold 16,515 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $147K.
  • Siren LLC first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2024 and held it in 6 quarters.
  • Siren LLC's Korsana Biosciences, Inc. Common Stock position peaked at $374K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.